NCT03165045

Brief Summary

The objective of this NIS is to measure changes in health status including functional status using CCQ scores in COPD patients receiving treatment with Spiolto® Respimat® according to label after approximately 6 weeks in routine clinical practice.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,351

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2017

Geographic Reach
1 country

108 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 11, 2017

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 24, 2017

Completed
2 days until next milestone

Study Start

First participant enrolled

May 26, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 24, 2019

Completed
1 year until next milestone

Results Posted

Study results publicly available

April 1, 2020

Completed
Last Updated

April 9, 2020

Status Verified

April 1, 2020

Enrollment Period

1.7 years

First QC Date

May 11, 2017

Results QC Date

March 18, 2020

Last Update Submit

April 1, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Therapeutic Success

    The primary endpoint of the study was "therapeutic success" at visit 2. The CCQ questionnaire contained 10 questions about symptoms, functional status and mental status. Each of the 10 CCQ questions was scored by the patient on a 7-point scale between 0 and 6 at baseline and at the end of observation after approximately 6 weeks. The sum of the scores divided by 10 gives the CCQ score which measures the health and functional status. A higher CCQ score is indicative of worse status. A decrease of 0.4 points is considered to be the minimal clinically important difference (MCID) for both CCQ score and CCQ-4.

    Final visit at the end of the study, approximately 6 weeks after start of study

Secondary Outcomes (4)

  • Assessment of Changes in CCQ and CCQ-4 From Visit 1 to Visit 2

    Final visit at the end of the study, approximately 6 weeks after start of study

  • General Condition of the Patient

    Baseline visit (Visit 1) at the start of the study and final visit at the end of the study (visit 2), approximately 6 weeks after visit 1

  • Patient Satisfaction With Spiolto® Respimat® at Visit 2

    6 weeks

  • Number of Participants Willing to Continue Treatment With Spiolto® Respimat® at Visit 2

    6 weeks

Study Arms (1)

patients treated with Spiolto® Respimat®

Patients with COPD

Drug: Spiolto® Respimat®

Interventions

6 weeks

Also known as: INSPIOLTO, SPIOLTO, STIOLTO, VAHELVA, YANIMO
patients treated with Spiolto® Respimat®

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

approximately 1300 patients from approximately 400 sites in Germany will be collected. Site selection will be performed to reflect routine COPD care in Germany in order to secure representativeness of the COPD population.

You may qualify if:

  • Patients can be included if all of the following criteria are met:
  • Written informed consent prior to participation
  • Female and male patients ≥40 years of age
  • Patients diagnosed with COPD and requiring a combination of two long-acting bronchodilators (LAMA + LABA) according to approved SmPC and GOLD COPD guideline recommendation 2017 (GOLD COPD groups B to D)
  • Treatment with Spiolto® Respimat® acc. to SmPC at the discretion of the physician.

You may not qualify if:

  • Patients with contraindications according to Spiolto® Respimat® SmPC
  • Patients already on a LABA/LAMA combination (free and fixed dose) in the last 6 weeks before study entry
  • Patients continuing LABA-ICS treatment should not be additionally treated with Spiolto® Respimat® in order to avoid a double dosing of long-acting beta-agonists
  • Pregnancy and lactation
  • Current participation in any clinical trial or any other non-interventional study of a drug or device.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (108)

Dr. Weghmann

Aachen, 52066, Germany

Location

Praxis Edgar Schaubert

Aldenhoven, 52457, Germany

Location

MZM Medizin Zentr. Marienstrasse

Aldenhoven B Jülich, 52457, Germany

Location

Praxis Dr. Selbig

Ansbach, 91522, Germany

Location

Dr. Ludwig

Bad Bentheim, 48455, Germany

Location

Dr. Jung

Bad Ditzenbach, 73342, Germany

Location

Praxis Dr. med. Graubner

Bad Sachsa, 37441, Germany

Location

Dr. Callitsis

Bad Vilbel, 61118, Germany

Location

Dr. Junggeburth

Bad Wörishofen, 86825, Germany

Location

Praxis Edgar Hossbach

Berkatal-Frankershausen, 37297, Germany

Location

Dr. Urban

Berlin, 10711, Germany

Location

Praxis Abdullah Sahan

Berlin, 12049, Germany

Location

Dr. Kopf

Berlin, 12459, Germany

Location

Dr. Thalhofer

Berlin, 14163, Germany

Location

Gemeinschaftspraxis Dres. Wetterau/Dimar

Biberach, 88400, Germany

Location

Dr. Kassik

Bitterfeld-Wolfen, 06749, Germany

Location

Dr. Biedermann

Blankenhain , Thür, 99444, Germany

Location

Praxis Dr. Andreas Schwittay

Böhlen, 04564, Germany

Location

Gemeinschaftspraxis Dres. Bartels

Breuberg, 64747, Germany

Location

Dres. Ottlewski/Sutor

Burgwedel, 30938, Germany

Location

Praxis B. Metzlaff

Büchen, 21514, Germany

Location

Praxis A. Hermann/L. Hermann

Cloppenburg, 49661, Germany

Location

Praxis Dr. Käßner

Cottbus, 03050, Germany

Location

Dres. Forster/Kneser/Steinmetz

Darmstadt, 64283, Germany

Location

Dres. Jung/Jung

Deggingen, 73326, Germany

Location

Dr. Franz

Dietzenbach, 63128, Germany

Location

Dres. Tietjens/Tobias

Dortmund, 44135, Germany

Location

Dr. Schwiese

Duisburg, 47051, Germany

Location

Dr. Kontny

Duisburg, 47055, Germany

Location

Dres. Berger/Schäfer/Winkels

Düren, 52349, Germany

Location

Gemeinschaftspraxis Dres. Rommelmann/Lange/Geist/Neise

Düsseldorf, 40217, Germany

Location

Ges. f. Med. Fortbildung

Düsseldorf, 40547, Germany

Location

Praxis Dr. Andreas Kroll

Einbeck, 37574, Germany

Location

Dr. Schmidt

Erfurt, 99084, Germany

Location

Dres. Brüning/Schax

Essen, 45134, Germany

Location

Praxis Dr. Schmorell

Forchheim, 91301, Germany

Location

Dres. Engelhard/Wihl

Frankenberg, 35066, Germany

Location

Studienzentrum Dr. Klaus Keller

Frankfurt, 60389, Germany

Location

Dr. Morgner

Freiberg, 09599, Germany

Location

Allgemeinmedizinische Gemeinschaftspraxis Dres. Fischer/Fischer

Friedrichsthal, 66299, Germany

Location

Dr. Xanthopoulos

Fürstenwalde, 15517, Germany

Location

Praxis A. Heinze

Fürstenwalde, 15517, Germany

Location

Dr. Sommer

Garmisch-Partenkirchen, 82467, Germany

Location

Praxis C. Staack/Z. Zadrozny

Gelsenkirchen, 45891, Germany

Location

Praxis Dr. Körössy

Geretsried, 82538, Germany

Location

Das HausarztZentrum

Grafenrheinfeld, 97506, Germany

Location

Dres. Koenen & Partner

Grafenrheinfeld, 97506, Germany

Location

Praxis Dr. med. Werner Gams

Gütersloh, 33330, Germany

Location

Dr. Waida

Haan, 42781, Germany

Location

Pneumologicum Halle

Halle, 06108, Germany

Location

Praxis J. Lemke

Halle, 06110, Germany

Location

Dr. Polke

Hamburg, 20357, Germany

Location

Praxis Dr. Kaase

Hamburg, 22529, Germany

Location

Dr. Abenhardt

Heidelberg, 69115, Germany

Location

Praxis J. Hinrichs-Pavlik

Heidelberg , Neckar, 69115, Germany

Location

Praxis Dr. Constance Koch

Heilbad Heiligenstadt, 37308, Germany

Location

Praxis J. Korsakas

Heudeber, 38855, Germany

Location

Praxis Dres. Berg & Partner

Höchstadt an der Aisch, 91315, Germany

Location

Dr. Schulze

Jerichow, 39319, Germany

Location

Ambulantes Zentrum

Kalawa, 03205, Germany

Location

Dr. Schmitz

Kall, 53925, Germany

Location

Praxis Dr. Bernhard Beckmann

Kamen, 59174, Germany

Location

Praxis G. Mohanty

Kamp-Lintfort, 47475, Germany

Location

Praxis Dr. Dietrich Auge

Koblenz, 56068, Germany

Location

Dres. Lehmann/Schwerdtfeger

Köthen, 06366, Germany

Location

Praxis Dr. Astrid Pfitzer

Kronach, 96317, Germany

Location

KMG Klinikum Mitte GmbH

Kyritz , Prignitz, 16866, Germany

Location

Praxis Dr. Weberling

Lahnau, 35633, Germany

Location

POIS Leipzig GbR

Leipzig, 04357, Germany

Location

Dres. Bonitz/Hoheisel

Leipzig, 4275, Germany

Location

Dr. Seiz

Leonberg , Württ, 71229, Germany

Location

Praxis Dr. Hannelore Pitule

Ludwigshafen am Rhein, 67061, Germany

Location

Dres. Kock & Partner

Mainaschaff, 63814, Germany

Location

Dr. Saur

Mannheim, 68161, Germany

Location

Praxis Dr. Hermann A. Trauth

Marburg, 35037, Germany

Location

Gemeinschaftspraxis Dres. Jansen/Nolzen

Menden, 58706, Germany

Location

Dr. Bartsch

Moers, 47441, Germany

Location

Dr. Schipper

Monheim, 86653, Germany

Location

Praxis Hermann Ingerl

Mosbach, 74821, Germany

Location

Praxis Dr. Jan Feimer

München, 80539, Germany

Location

Thoraxzentrum Bez. Unterfranken

Münnerstadt, 97702, Germany

Location

Praxis Dipl. med Thomas Hagen

Neumarkt, 92318, Germany

Location

Praxis Wanda Wuttke

Nuremberg, 90478, Germany

Location

Praxis Dr. Volker E. Trapp

Nuremberg, 90489, Germany

Location

Praxis Dipl.-med. Anne-Kathrin Schmidt

Oschatz, 04758, Germany

Location

Dr. Bauer

Potsdam, 14480, Germany

Location

Praxis Dr. Rudolf Hennig

Radebeul, 01445, Germany

Location

Dr. Jasch-Hoppe

Rathenow, 14712, Germany

Location

Zentrum für Onkologie

Rostock, 18107, Germany

Location

Dres. Herold/Kaa

Roth , Mittelfr, 91154, Germany

Location

Lungenfachzentrum Rhein-Main

Rüsselsheim am Main, 65428, Germany

Location

MVZ für Atemwegserkrankungen

Schleswig, 24837, Germany

Location

Praxis S. Theuer

Seelow, 15306, Germany

Location

Dres. Knöbel/Olesch/Pelz-Knöbel

Straubing, 94315, Germany

Location

Dr. Eisenschmidt

Strausberg, 15344, Germany

Location

Dr. Schröter

Trier, 54290, Germany

Location

Dres. Barczok & Kollegen

Ulm, Donau, 89073, Germany

Location

Dres. Günther/Günther

Viernheim, 68519, Germany

Location

Überörtliche Gemeinschaftspraxis Dr. med. Albert Esselmann

Warendorf, 48231, Germany

Location

Dres. Herold/Kaa

Weißenburg I Bay, 91781, Germany

Location

Dres. Geissler/Geissler

Weißenfels, Saale, 06667, Germany

Location

Dres. Seidel/Röcher

Wiefelstede, 26215, Germany

Location

Dres. Fried/Thomas

Wiesbaden, 65183, Germany

Location

Praxis K.P. Schaps/H. Zimmeck

Wilhelmshaven, 26388, Germany

Location

Dr. Franz

Witten, 58452, Germany

Location

Dr. Weber

Witten, 58452, Germany

Location

Praxis D. Kubitscheck

Wittenberg, 06886, Germany

Location

Dr. Riegel

Wolfsburg, 38448, Germany

Location

Related Publications (1)

  • Gillissen A, Marseille A, Skowasch D, Ritz J, Mattiucci-Guehlke M, Pabst S, Greulich T, Koczulla R. Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL(R) non-interventional study. ERJ Open Res. 2021 Sep 6;7(3):00004-2021. doi: 10.1183/23120541.00004-2021. eCollection 2021 Jul.

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Boehringer Ingelheim, Call Center
Organization
Boehringer Ingelheim

Study Officials

  • Andrea Marseille, 49613277141881

    andrea.marseille@boehringer-ingelheim.com

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2017

First Posted

May 24, 2017

Study Start

May 26, 2017

Primary Completion

February 4, 2019

Study Completion

March 24, 2019

Last Updated

April 9, 2020

Results First Posted

April 1, 2020

Record last verified: 2020-04

Locations